The Menthol Loophole: Why Menthol Cigarettes Are a Racial Justice Issue

In 2009, when the U.S. Congress passed the Family Smoking Prevention and Tobacco Control Act giving the FDA authority over tobacco products, it banned flavored cigarettes—strawberry, vanilla, chocolate, clove—to prevent them from enticing children. But one flavor was conspicuously exempted: menthol. The exemption was not scientific. Internal tobacco industry documents, later revealed in litigation, showed that companies had deliberately targeted menthol marketing at Black communities since the 1950s, cultivating a customer base that by the 2020s would see 85% of Black smokers using menthol cigarettes, compared to 29% of white smokers. What began as a regulatory compromise has calcified into one of the starkest examples of racial health inequity in American public health.

The numbers are devastating. The CDC estimates that menthol cigarettes are responsible for 10,000 premature deaths among Black Americans annually, and that a menthol ban would save 654,000 lives over 40 years—255,000 of them Black. Menthol's cooling, anesthetic effect masks the harshness of cigarette smoke, making it easier to start and harder to quit. Studies consistently show that menthol smokers have lower quit success rates than non-menthol smokers, even after controlling for socioeconomic factors. The industry understood this chemistry intimately: internal documents describe menthol as a 'smoothing agent' that 'makes the smoke seem less harsh' and facilitates 'deeper inhalation.' This wasn't an accident of product design. It was the point.

The FDA has been formally considering a menthol ban since 2011, when its own Tobacco Products Scientific Advisory Committee concluded that 'removal of menthol cigarettes from the marketplace would benefit public health in the United States.' More than a decade later, the ban has not materialized. The FDA announced its intention to propose a rule in 2021 and finally issued proposed rules in 2022, but the final rule has been repeatedly delayed. The official explanation involves the complexity of the rulemaking process and the volume of public comments—over 250,000 were submitted. The unofficial explanation, widely reported by investigative journalists and acknowledged by public health advocates, is intense political pressure from the tobacco industry and its allies, who have framed a menthol ban as government overreach that would criminalize products used disproportionately by Black communities.

This framing—that a menthol ban would harm the very communities it's intended to protect—is a masterpiece of political judo. The tobacco industry has funded civil rights organizations, sponsored Black cultural events, and cultivated relationships with Black political leaders for generations, building a reservoir of goodwill that it now draws upon to argue against regulation. 'A menthol ban would create an illicit market and lead to more police interactions with Black communities,' the argument goes. It's a potent message in an era of criminal justice reform, and it has successfully split the civil rights community. Some organizations, including the NAACP and the Congressional Black Caucus, support the ban. Others, including some state-level Black leadership groups that have received tobacco industry funding, oppose it.

The criminalization concern deserves honest engagement. A poorly implemented ban could indeed lead to over-policing of Black communities if enforcement targets individual possession rather than retail sales and manufacturing. The solution is not to abandon the ban but to design it carefully: enforce against retailers, manufacturers, and distributors—not individual smokers; couple the ban with increased funding for cessation services in affected communities; and explicitly prohibit law enforcement from using the ban as a pretext for stops, searches, or arrests of individuals. Several proposed state-level menthol bans have included these safeguards, demonstrating that the tension between public health and criminal justice is real but solvable with intentional policy design.

The international experience provides a preview. Canada implemented a nationwide menthol ban in 2017, and a subsequent study in *JAMA* found that menthol smokers were significantly more likely to attempt and succeed at quitting than those in jurisdictions without a ban. The EU banned menthol cigarettes in 2020. The UK included menthol in its broader flavor ban. None of these jurisdictions experienced significant black-market disruption, enforcement crises, or the apocalyptic consequences the industry predicts. The primary outcome was straightforward: fewer people smoked menthol cigarettes, and more people quit. The sky did not fall. The criminal justice system did not implode.

The menthol ban is not, fundamentally, a science question. The science has been settled for over a decade. It's a political question about whose interests the government prioritizes: the 45,000 Black Americans who die annually from smoking-related diseases, or an industry that has profited from those deaths for generations. Every year of delay is not neutral—it's a policy choice with a body count. As Dr. Phillip Gardiner, a leading researcher on menthol and health equity, told a congressional hearing: 'If menthol cigarettes were killing 10,000 white Americans a year, do you think we'd still be having this conversation?'